Skip to main content
. 2022 Mar 25;56(14):792–800. doi: 10.1136/bjsports-2020-103405

Table 2.

Baseline characteristics of participants

Early lengthening (N=44*) Delayed lengthening (N=44*)
Age (years) 26 (±4) 25 (±5)
Gender (male) 44 (100%) 44 (100%)
Sports
 Football 30 (68.2%) 27 (61.4%)
 Futsal 3 (6.8%) 2 (4.5%)
 Handball 4 (9.1%) 5 (11.4%)
 Basketball 4 (9.1%) 4 (9.1%)
 Athletics 1 (2.3%) 4 (9.1%)
 Volleyball 1 (2.3%) 0
 Field hockey 1 (2.3%) 1 (2.3%)
 Rugby 0 1 (2.3%)
Level of sports
 Professional 40 (90.9%) 42 (95.5%)
 Competitive 4 (9.1%) 2 (4.5%)
Previous hamstring injury, n (%) 21 (47.7%) 21 (47.7%)
Previous ipsilateral hamstring injury, n (%) 13 (29.5%) 17 (38.6%)
Previous ipsilateral hamstring autograft for ACL reconstruction, n (%) 2 (4.5%) 0
Injury during
 Match, n (%) 32 (72.7%) 32 (72.7%)
 Training, n (%) 12 (27.3%) 12 (27.3%)
Time of injury during match or training, n (%)
 Beginning (first quarter) 5 (12.5%) 15 (36.6%)
 Middle (second/third quarter) 16 (40%) 12 (29.3%)
 End (fourth quarter) 19 (47.5%) 14 (34.1%)
Mechanism of injury, n (%)
 Sprinting 26 (59.1%) 26 (59.1%)
 Stretching 5 (11.4%) 3 (6.8%)
 Kicking/shooting 5 (11.4%) 5 (11.4%)
 High kick 0 (0%) 1 (2.3%)
 Sliding/tackling 3 (6.8%) 0 (0%)
 Other 5 (11.4%) 9 (20.5%)
Dominant leg injured, n (%) 30 (69.8%) 27 (61.4%)
Training per week (in hours) 10.1 (±3.5) 10.6 (±3.6)
Time between injury and start of blinded assessment or rehabilitation (in days) 2 (IQR 2–4) 3.5 (IQR 2–4)
Max pain at time of injury (NRS 0–10) 7 (IQR 6–8) 7.8 (IQR 5.8–9)
Participant predicted RTS (in days) 14 (IQR 10–21) 14 (IQR 10–18)
Participant expectation of performance after recovery (as compared with before injury, in %) 100 (IQR 100–101) 100 (IQR 100–120)
Palpation pain at blinded assessment (yes/no) 40/4 41/3
Length of palpation pain (in cm) 7 (IQR 5.3–12) 8.5 (IQR 6–10.5)
Width of palpation pain (in cm) 4.5 (IQR 3.5–6.8) 5.5 (IQR 4–7.5)
Distance from ischium to maximal painful area on palpation (in cm) 15.6 (±7.4) 13.9 (±7.8)
Range of motion
 PKET relative deficit (in % of uninjured leg) 59.8 (IQR 38.8–86.9) 66.1 (IQR 39.8–91.1)
 SLR relative deficit (in % of uninjured leg) 72.7 (IQR 60.1–93.9) 81.9 (IQR 62.1–91.7)
 MHFAKE relative deficit (in % of uninjured leg) 58 (IQR 40.9–83.9) 59.2 (IQR 19–88)
Strength
 Able to do ‘inner’ test (yes/no) 42/2 43/0
 ‘Inner’ position relative deficit (compared with contralateral leg, in %) 73 (IQR 47–81.5) 72.1 (IQR 49.5–82)
 Able to do ‘mid’ test (yes/no) 41/3 44/0
 ‘Mid’ position relative deficit (compared with contralateral leg, in %) 58.8 (±30.7) 50 (±26.3)
 Able to do ‘’outer’ test (yes/no) 41/3 42/2
 ‘Outer’ position relative deficit (compared with contralateral leg, in %) 38.9 (IQR 29.7–53.7) 36.6 (IQR 24.3–56.5)
MRI
Injury location, n (%)
 Biceps Femoris long head 36 (82%) 37 (84%)
 Biceps femoris short head 0 0
 Semimembranosus 5 (11%) 6 (14%)
 Semitendinosus 3 (7%) 1 (2%)
Grade I/II (modified Peetrons), n (%)
 Grade I 20 (45%) 18 (41%)
 Grade II 24 (55%) 26 (59%)
Oedema craniocaudal length (in cm) 13.5 (IQR 8.9–19.4) 15.8 (IQR 11.1–22.6)
Cross-sectional area of injury (in % of maximum CSA of the involved muscle) 61.5 (IQR 36.6–86.1) 58.5 (IQR 44.3–85)
Distance from ischial tuberosity to (in cm):
 Start of oedema 15.2 (IQR 8.5–22.3) 11.8 (IQR 5.5–20)
 Maximal SI of oedema 23.4 (IQR 15.4–28.4) 22.4 (IQR 16.3–25.8)
Intramuscular tendon involvement, n (%) 26 (59%) 28 (64%)
 0% (no involvement) 18 (40.9%) 16 (36.4%)
 <50% CSA 9 (20.5%) 10 (22.7%)
 50%–99% CSA 9 (20.5%) 12 (27.3%)
 100% CSA 8 (18.2%) 6 (13.6%)
Compliance to rehabilitation (in %) 77 (IQR 60–96) 76 (IQR 63–90)

*For cases that do not add up to 44, data were missing.

ACL, anterior cruciate ligament; CSA, cross-sectional area; Inner, prone knee flexion 90°; MHFAKE, Maximum Hip Flexion Active Knee Extension test; Mid, prone knee flexion 30°; NRS, Numeric Rating Scale; Outer, supine knee/hip flexion 90°/90; PKET, Passive Knee Extension Test; SI, signal intensity; SLR, Straight Leg Raise test.